LLY

1,028.57

-2.76%↓

JNJ

206.11

+0.84%↑

ABBV

225.87

+0.67%↑

UNH

328.37

+0.54%↑

AZN

90.57

-0.1%↓

LLY

1,028.57

-2.76%↓

JNJ

206.11

+0.84%↑

ABBV

225.87

+0.67%↑

UNH

328.37

+0.54%↑

AZN

90.57

-0.1%↓

LLY

1,028.57

-2.76%↓

JNJ

206.11

+0.84%↑

ABBV

225.87

+0.67%↑

UNH

328.37

+0.54%↑

AZN

90.57

-0.1%↓

LLY

1,028.57

-2.76%↓

JNJ

206.11

+0.84%↑

ABBV

225.87

+0.67%↑

UNH

328.37

+0.54%↑

AZN

90.57

-0.1%↓

LLY

1,028.57

-2.76%↓

JNJ

206.11

+0.84%↑

ABBV

225.87

+0.67%↑

UNH

328.37

+0.54%↑

AZN

90.57

-0.1%↓

Search

Moleculin Biotech Inc

Open

6.77 3.52

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

6.46

Max

6.65

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+0.6% upside

Moleculin Biotech Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

2. Dez. 2025, 17:29 UTC

Wichtige Markttreiber
Akquisitionen, Fusionen, Übernahmen

Laurentian Bank Shares Hit Two-Year High on Plans for Break-Up, Takeover

2. Dez. 2025, 16:21 UTC

Ergebnisse

Scotiabank Aiming for Earnings Growth After Capital Markets Buoy Results in Latest Quarter -- Update

2. Dez. 2025, 16:18 UTC

Ergebnisse

Correction to Scotiabank Quarterly Earnings Buoyed Article

2. Dez. 2025, 23:53 UTC

Market Talk

Nikkei May Rise After Gains on Wall Street -- Market Talk

2. Dez. 2025, 22:48 UTC

Ergebnisse

Marvell's Stock Soars On Data Center Forecast -- Barrons.com

2. Dez. 2025, 22:12 UTC

Market Talk

Australian 3Q GDP To Show Modest Recovery In Play -- Market Talk

2. Dez. 2025, 22:03 UTC

Market Talk

Minerals 260's Resource Upgrade Looks Impressive -- Market Talk

2. Dez. 2025, 22:00 UTC

Market Talk

Global Equities Roundup: Market Talk

2. Dez. 2025, 22:00 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

2. Dez. 2025, 22:00 UTC

Market Talk

Fletcher Building Loses Bull Due to Tame Housing-Market Recovery -- Market Talk

2. Dez. 2025, 21:56 UTC

Ergebnisse

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2. Dez. 2025, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

2. Dez. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

2. Dez. 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

2. Dez. 2025, 21:44 UTC

Ergebnisse

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2. Dez. 2025, 21:38 UTC

Market Talk

Sky Network TV Has Path to Grow Dividend by 33% -- Market Talk

2. Dez. 2025, 21:19 UTC

Ergebnisse

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2. Dez. 2025, 20:06 UTC

Market Talk

Oil Futures Fall Amid Russia-Ukraine Peace Talks -- Market Talk

2. Dez. 2025, 19:55 UTC

Market Talk

Natural Gas Futures Fall Amid Uncertain Weather Forecasts -- Market Talk

2. Dez. 2025, 19:53 UTC

Market Talk
Ergebnisse

Global Equities Roundup: Market Talk

2. Dez. 2025, 19:53 UTC

Market Talk
Ergebnisse

Scotiabank ROE Target Viewed as Possibly Conservative -- Market Talk

2. Dez. 2025, 19:24 UTC

Market Talk

Analysts Project Uptick in U.S. Ethanol Stocks -- Market Talk

2. Dez. 2025, 19:06 UTC

Market Talk

Precious Metals Step Back After Silver Sets Record -- Market Talk

2. Dez. 2025, 18:27 UTC

Akquisitionen, Fusionen, Übernahmen

Kraken to Acquire Backed Finance AG

2. Dez. 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

2. Dez. 2025, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

2. Dez. 2025, 15:17 UTC

Market Talk

Natural Gas Extends Gains Amid Cold Weather -- Market Talk

2. Dez. 2025, 14:47 UTC

Market Talk

BOE Likely to Cut Rates Further, Weakening Sterling -- Market Talk

2. Dez. 2025, 14:38 UTC

Market Talk

Silver Steps Back From Record Levels -- Market Talk

2. Dez. 2025, 14:31 UTC

Market Talk
Ergebnisse

Scotiabank Strong Quarter Driven By Capital Markets Growth -- Market Talk

Peer-Vergleich

Kursveränderung

Moleculin Biotech Inc Prognose

Kursziel

By TipRanks

0.6% Vorteil

12-Monats-Prognose

Durchschnitt 6.67 USD  0.6%

Hoch 12 USD

Tief 4 USD

Basierend auf 3 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Moleculin Biotech Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

3 ratings

3

Buy

0

Halten

0

Sell

Finanzen

$

help-icon Live chat